The Role of Immunology in Forensic Science

Every immunological test in the forensic laboratory depends on the same molecular event: an antibody's variable region binds its cognate antigen through non-covalent interactions including hydrogen bonds, van der Waals forces, hydrophobic contacts, and electrostatic attraction. The binding is reversible but under physiological conditions the affinity is high enough to make it effectively stable. Specificity is the defining property: a well-characterised antibody raised against human serum albumin will bind human albumin and not the albumin of other species, which is the chemical basis for species testing.

Two classical outcomes of antigen-antibody binding are exploited in forensic serology. First, when antibodies cross-link multiple soluble antigen molecules, they form lattice complexes that grow until they precipitate from solution. This is the precipitin reaction, used in the Ouchterlony test and the ring precipitin test. Second, when antibodies bind antigens on the surface of particles such as red blood cells or latex beads, they cause the particles to clump together. This is agglutination, used in ABO blood grouping. Both reactions are concentration-dependent: too little antibody (prozone effect) or too much (hook effect) can suppress the visible response, a source of false-negative results if not controlled.

Modern immunoassays add an amplification step to increase sensitivity below the threshold of the classical precipitin and agglutination tests. In ELISA, an enzyme covalently attached to the detection antibody converts a colourless substrate to a coloured product; the optical density of the colour is proportional to the amount of antigen captured. In radioimmunoassay (RIA), a radiolabelled competitor or tracer provides the signal. In lateral-flow strips, colloidal gold or coloured latex particles conjugated to the detection antibody accumulate at a capture line to produce a visible band. Each amplification strategy increases sensitivity, allowing detection of antigen in nanogram or picogram quantities from small or degraded forensic samples.

The ABO system, described by Karl Landsteiner in 1901, remains the most forensically important blood group system. It classifies individuals into four phenotypes based on the oligosaccharide antigens expressed on the surface of red blood cells: type A (antigen A), type B (antigen B), type AB (both antigens), and type O (neither antigen). Crucially, individuals carry natural antibodies against the antigens they lack: a type A person has anti-B antibodies in their serum, and a type B person has anti-A antibodies. This reciprocal antibody pattern, called Landsteiner's rule, underpins the compatibility requirements for blood transfusion and provides the reagent mechanism for ABO typing.

The Rh system adds further discriminating power. The D antigen is the most immunogenic Rh antigen; approximately 85 percent of European populations are Rh-positive (express D) and 15 percent are Rh-negative (do not express D). Unlike ABO antibodies, anti-D antibodies are not naturally occurring; they arise only after exposure to D-positive red cells through transfusion or pregnancy. The forensic utility of Rh typing is limited compared with ABO because anti-D reagents are less stable and Rh antigens deteriorate more rapidly in dried stains. Minor blood group systems (MNS, Kell, Duffy, Kidd) provide additional discriminating markers but require specialist antisera and are used selectively rather than routinely. Read more on the ABO Blood Group System and Rh Blood Group System pages for full antigenic details.

In a criminal investigation, blood group typing of a stain produces a phenotype that can be compared with the victim's and suspect's known groups. The result either excludes the suspect as the source of the stain, is consistent with the suspect being the source, or is uninformative. Blood group evidence is population-frequency evidence: a type O result is consistent with approximately 44 percent of people of European ancestry, which limits its discriminating value in isolation. The value increases when blood group typing is combined with other markers or when it excludes a suspect categorically.

Before a forensic serologist proceeds to blood grouping or body fluid identification, the species origin of the biological material must be confirmed. In cases of suspected poaching, animal cruelty, or contamination of a human bloodstain with animal blood, species testing is itself the primary question. The classical method is the precipitin test using species-specific antiserum.

Paul Uhlenhuth developed the precipitin test for species identification in 1901, the same year Landsteiner published the ABO system. Uhlenhuth immunised rabbits with human serum proteins, then added the resulting antiserum to bloodstain extracts in tubes; a white precipitate formed only in tubes containing human blood. His test was used almost immediately in a murder investigation in Germany, making it one of the first immunological tests to be applied forensically. In the Ouchterlony double-diffusion format, the stain extract and the antiserum are placed in separate wells punched into an agar gel. Both diffuse outward and form a visible precipitin line where they meet at equivalence. The position and shape of the line can also reveal cross-reactive species: human and great ape sera may form a spur (a partial line extension) because their proteins share some antigenic determinants but differ enough to produce a visible distinction.

Modern laboratories increasingly use ELISA or PCR-based species identification, particularly for heavily degraded samples where protein antigenicity is lost. However, the precipitin test remains in use in teaching laboratories and in some jurisdictions as a reference method, and understanding its mechanism is necessary to interpret historical case records where it was used as evidence.

Identifying the nature of a biological stain (blood, semen, saliva, vaginal secretion, urine, or other fluid) is a foundational step in trace evidence analysis. Each fluid contains specific marker proteins whose presence can be confirmed immunologically. The key forensic markers are: haemoglobin and its breakdown products for blood, prostate-specific antigen (PSA, also called p30) for semen, salivary amylase (also known as alpha-amylase) for saliva, and human neutrophil elastase or other markers for vaginal secretions.

PSA became the preferred semen marker after systematic evaluation showed that it is present at high concentration in seminal plasma, is not normally present in other body fluids at comparable levels, and can be detected by commercially available antibodies. The lateral-flow strip test for PSA (the ABAcard HemaTrace p30 test and similar products) is now widely used as a rapid field and laboratory screening tool. A positive PSA result is consistent with semen but not proof of intercourse; PSA can be detected in cervicovaginal fluid for several days after consensual intercourse, which courts must understand when the test is presented as evidence in sexual offence cases.

The sandwich ELISA format is well suited to quantitative body fluid identification: a capture antibody specific to the target protein is coated on the plate, the sample is added, and a second detection antibody (enzyme-tagged) binds the captured antigen from a different epitope. This two-antibody design increases specificity compared with a direct ELISA. Salivary amylase ELISA, for example, can detect nanogram quantities of amylase in swabs from bite marks, licked envelopes, or cigarette ends. The sensitivity is a practical advantage but also a cross-contamination risk: amylase is ubiquitous in human environments, and contamination controls are mandatory.

The ABH antigens that define ABO blood group are expressed on red blood cell surfaces and in many body secretions in individuals who carry a functional copy of the FUT2 (Se) gene. These individuals, called secretors, release A, B, and H antigens into saliva, semen, vaginal secretions, sweat, gastric juice, and tears. Non-secretors, who are homozygous recessive for the FUT2 gene, do not secrete these antigens into body fluids. The secretor phenotype is present in roughly 78 to 80 percent of most populations studied, with some variation by ethnic group.

Forensic implications are significant. A saliva stain from a secretor can be typed for ABO blood group using an absorption-inhibition or cross-over electrophoresis technique. A saliva stain from a non-secretor will yield no ABO result, which is itself informative: if a stain yields no ABO result from a sample that appears to contain adequate biological material, non-secretor status should be considered. Secretor status can be typed directly from DNA in modern practice, removing the ambiguity of a negative serological result.

The absorption-elution technique extends ABO typing to dried bloodstains even when the sample is too small for direct agglutination. The stain is treated with a specific antiserum (anti-A or anti-B); if the complementary antigen is present, the antibodies are absorbed onto the stain. The stain is washed to remove unabsorbed antibodies and then heated, which releases (elutes) the absorbed antibodies into solution. The eluate is tested against known A and B red cells: agglutination in the eluate confirms which antigen was present in the original stain. This method can produce ABO types from very small, degraded stains but requires rigorous controls because elution is not perfectly specific.

Before DNA profiling became available in the late 1980s, parentage disputes in forensic and civil contexts were resolved using a battery of serological markers. ABO, Rh, MNS, Kell, Duffy, and Kidd blood groups, together with HLA typing and red cell enzyme polymorphisms, could not confirm parentage but could exclude a putative father if he lacked a marker that the child must have inherited. The combined exclusion probability of a full serological battery reached 95 to 99 percent in many populations, meaning that a non-father had a 95 to 99 percent chance of being excluded by the tests. A man who was not excluded by serological testing was said to be a possible father, not a confirmed one.

DNA STR profiling has displaced serological parentage testing in most jurisdictions because it provides power of exclusion exceeding 99.99 percent and individuating inclusion probabilities in the quadrillions. Serological relationship testing is now primarily of historical interest, but forensic examiners reviewing legacy case files or working in resource-limited settings where STR profiling is unavailable may still encounter serological parentage results. The critical point is that serological inclusion evidence was always population-frequency evidence, not identity evidence, and historical cases where it was presented as more powerful than this should be re-evaluated.

International standards for relationship testing now uniformly require DNA-based methods. In the United States, AABB (formerly the American Association of Blood Banks) accreditation standards require STR testing. In the United Kingdom, the Ministry of Justice requires accredited laboratories and DNA testing for immigration and family law cases. Under India's DNA Technology (Use and Application) Regulation Bill (pending enactment), and existing provisions of the Bharatiya Sakshya Adhiniyam 2023, forensic biological evidence is admissible when produced by accredited methods, which in practice means DNA profiling. Serological results may still be admissible in principle but carry far less weight.